Company Name: Bionomics
Announcement Date: 13/09/2016
Announcement Category: Awards/recognition, Other, Product launch/update, Special Offer
Announcement Content:
Bionomics (ASX:BNO) to Present at Rodman & Renshaw NY Global Investment Conference
Melbourne, Australia, September 12 2016 – Bionomics Limited (ASX: BNO, OTCQX:BNOEF), a biopharmaceutical company focused on the discovery and development of innovative therapeutics for the treatment of diseases of the central nervous system (CNS) and cancer, will present at the Rodman & Renshaw's 18th Annual Global Investment Conference, at the Lotte New York Palace Hotel, New York City 11-13 September 2016.
Bionomics’ presentation will take place on Tuesday 13 September 2016 at 5:30pm in the Holmes II room (4th Floor). Bionomics will also participate in one-on-one meetings with investors at the conference. A copy of the slide deck will be available on Bionomics’ website following the presentation.
Approximately 200 public and private companies are selected from across the globe to present at Rodman & Renshaw with an audience of more than 2,000 attendees who are predominantly financial and strategic investors. Held annually, the conference brings growth companies together with focus on healthcare, natural resources, technology, media and telecommunications.
FOR FURTHER INFORMATION PLEASE CONTACT:
Australia
Monsoon Communications
Rudi Michelson
+613 9620 3333
[email protected]
US
Stern IR, Inc.
Beth Del Giacco
+1 212 362 1200
[email protected]
Announcement URL: http://www.bionomics.com.au/upload/investors/announcements/4736/32752/ASX803%20Bionomics%20to%20present%20at%20Rodman%20and%20Renshaw%20announcement.pdf
About Bionomics:
Bionomics is an Adelaide-based biopharmaceutical company dedicated to making better treatments for cancer, central nervous system disorders such as anxiety, depression and Alzheimer's Disease. We are in a strong growth phase with our world-class portfolio of promising drug candidates from early to advanced stages of clinical development. At the core of our business is strategic partnering. We partner with large pharmaceutical companies to get our drugs through the later stages of development and into the market as rapidly as possible.
Go to Company Profile for: Bionomics
Announcement Contact: [email protected]
